作者：
Bespalov, Anton [1]
;
Steckler, Thomas [2]
;
Altevogt, Bruce [3]
;
Koustova, Elena [4]
;
Skolnick, Phil [5]
;
Deaver, Daniel [6]
;
Millan, Mark J. [7]
;
Bastlund, Jesper F. [8]
;
Doller, Dario [9]
;
Witkin, Jeffrey [10]
;
Moser, Paul [11]
;
O'Donnell, Patricio [12]
;
Ebert, Ulrich [13]
;
Geyer, Mark A. [14]
;
Prinssen, Eric [15]
;
Ballard, Theresa ;
Macleod, Malcolm
作者单位：
Alkermes, Nonclin Res & Dev, Waltham, MA 02451 USA
[1]
Boehringer Ingelheim Pharma GmbH & Co KG, D-55218 Ingelheim, Germany
[2]
Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev Neurosci Ophthalmol, CH-4070 Basel
[3]
AbbVie, Neurosci Res, D-6706 Ludwigshafen, Germany
[4]
Inst Rech Servier, F-78290 Croissy Sur Seine, France
[5]
Univ Calif San Diego, La Jolla, CA 92093 USA
[6]
Pfizer, Global Policy & Int Publ Affairs, New York, NY 10017 USA
[7]
Janssen Res & Dev, B-2340 Beerse, Belgium
[8]
Lundbeck Res USA, Discovery Chem & DMPK, Paramus, NJ 07652 USA
[9]
Pfizer, Neurosci & Pain Res Unit, Cambridge, MA 02139 USA
[10]
NIDA, NIH, Bethesda, MD 20892 USA
[11]
H Lundbeck & Co AS, Neurosci Res, DK-2500 Valby, Denmark
[12]
Univ Edinburgh, Old Coll, South Bridge, Edinburgh EH8 9YL, Midlothian, Scotland
[13]
Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA
[14]
Pierre Fabre Res Inst, F-81106 Castres, France
[15]
发布时间
2017-04-05
换一批
换一批
